Freshpet Masterbrand Logo RGB.png
UPDATE - Freshpet, Inc. to Participate in the Deutsche Bank Global Consumer Conference
May 29, 2024 17:30 ET | Freshpet, Inc.
SECAUCUS, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members of the executive management team will participate in the...
tarsus-logo-stacked-color-532x626.png
Tarsus to Participate in Upcoming Investor Conferences
May 29, 2024 17:00 ET | Tarsus Pharmaceuticals, Inc
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...
Descartes Systems Group Logo
Descartes Announces Fiscal 2025 First Quarter Financial Results
May 29, 2024 17:00 ET | The Descartes Systems Group Inc.
Record Revenues and Income from Operations WATERLOO, Ontario and ATLANTA, May 29, 2024 (GLOBE NEWSWIRE) --  The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results...
Lilium sq.png
Lilium Announces Successful Arrangement of $114 Million Capital Raise With Participation From Strategic and Existing Investors
May 29, 2024 17:00 ET | Lilium GmbH
MUNICH, Germany, May 29, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM) (“Lilium”), developer of the first all-electric vertical take-off and landing (eVTOL) jet and global pioneer in regional...
Reviva Logo.png
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 29, 2024 16:45 ET | Reviva Pharmaceuticals
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that...
Jasper.png
Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
May 29, 2024 16:30 ET | Jasper Therapeutics, Inc.
REDWOOD CITY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy...
Cellectis Logo.png
Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024
May 29, 2024 16:30 ET | Cellectis Inc.
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
ANI logo.png
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
May 29, 2024 16:30 ET | ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024...
X4-logo.png
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
May 29, 2024 16:30 ET | X4 Pharmaceuticals
BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will host...
sowgood_logo.jpg
Sow Good Signs Lease for New Distribution Facility in Dallas, Texas
May 29, 2024 16:30 ET | Sow Good Inc.
New 324,000 sq. ft. Facility Expected to Significantly Increase In-House Production Capacity Dallas Facility Expected to House All Incoming Additional Freeze Driers IRVING, Texas, May 29, 2024 ...